Cerberus Therapeutics logo
VerifiedBiotechnology Research· Founded 2022

Cerberus Therapeutics

Cerberus Therapeutics utilizes nanobody-based platform to create novel therapeutics for modulating the immune system. The COVID-19 pandemic highlights the need for safe and accessible therapies to modulate our immune responses. We have developed strategies that allows for precise turning on/off the immune system in response to debilitating diseases. Our pilot programs focus on autoimmune disorders and infectious diseases, that are based on novel biological discoveries originating from decades of work by our three founders: Dr. Novalia Pishesha, Prof. Hidde Ploegh, and Prof. Harvey Lodish.

7-day free trial · no credit card

HeadquartersCambridge, United StatesEmployees7(1 to 10)Founded year2022Websitecerberustx.comLinkedIn profileLinkedIn

Verified contacts

8

available on Kipplo

LinkedIn employees

7

1 to 10 range

Open roles

no listings

Distinct roles

6

indexed titles

Tech stack

2

tools in use

Monthly traffic

organic / mo

Sign up free to see all 8 verified contacts at Cerberus Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

8 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Cerberus Therapeutics

6 distinct titles indexed · top 6 shown.

  • 1board member
  • 1chief technology officer
  • 1founding member
  • 1research assistant
  • 1research associate
  • 1senior scientist

Sign up to unlock all 8 contacts at Cerberus Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 8 verified contacts at Cerberus Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Cerberus Therapeutics | Kipplo Discover